Market Estimates
Valuation Metrics
Financials
Trading Trends
INVA News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Innoviva Inc (INVA) stock price today?
The current price of INVA is 19.58 USD — it has decreased -0.36 % in the last trading day.
What is Innoviva Inc (INVA)'s business?
Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. The Company's royalty portfolio consists of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, the Company is entitled to receive royalties from GSK on sales of RELVAR/BREO, ELLIPTA. The Company's products include GIAPREZA (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA (eravacycline) approved for the treatment of complicated intra-abdominal infections in adults. The third product, XACDURO (formerly known as sulbactam-durlobactam or SUL-DUR), is approved for the treatment of hospital-acquired and ventilator-associated pneumonias caused by Acinetobacter in adults. The development pipeline includes zoliflodacin, an investigational treatment for uncomplicated gonorrhea is in Phase III clinical trial.
What is the price predicton of INVA Stock?
Wall Street analysts forecast INVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INVA is 32.00 USD with a low forecast of 17.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Innoviva Inc (INVA)'s revenue for the last quarter?
Innoviva Inc revenue for the last quarter amounts to 107.80M USD, increased 20.44 % YoY.
What is Innoviva Inc (INVA)'s earnings per share (EPS) for the last quarter?
Innoviva Inc. EPS for the last quarter amounts to 1.06 USD, increased 5200.00 % YoY.
What changes have occurred in the market's expectations for Innoviva Inc (INVA)'s fundamentals?
How many employees does Innoviva Inc (INVA). have?
Innoviva Inc (INVA) has 127 emplpoyees as of January 10 2026.
What is Innoviva Inc (INVA) market cap?
Today INVA has the market capitalization of 1.46B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260107060345_fd631ca9cc459953cfe9cd75ca0ad768.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F49ba51f686ae51aacd3883cd18bfb47a53f23d0c0b7c844c50647d1d950e9270.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)